Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department.

Walensky RP, Morris BL, Reichmann WM, Paltiel AD, Arbelaez C, Donnell-Fink L, Katz JN, Losina E.

PLoS One. 2011;6(10):e25575. doi: 10.1371/journal.pone.0025575.

2.

Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial.

Walensky RP, Reichmann WM, Arbelaez C, Wright E, Katz JN, Seage GR 3rd, Safren SA, Hare AQ, Novais A, Losina E.

Ann Emerg Med. 2011 Jul;58(1 Suppl 1):S126-32.e1-4. doi: 10.1016/j.annemergmed.2011.03.023.

3.

Novel emergency department registration kiosk for HIV screening is cost-effective.

Hsieh YH, Holtgrave DR, Peterson S, Gaydos CA, Rothman RE.

AIDS Care. 2016;28(4):483-6. doi: 10.1080/09540121.2015.1099603.

4.

Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.

Dowdy DW, Rodriguez RM, Hare CB, Kaplan B.

Acad Emerg Med. 2011 Jul;18(7):745-53. doi: 10.1111/j.1553-2712.2011.01110.x.

5.

The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial.

Schackman BR, Metsch LR, Colfax GN, Leff JA, Wong A, Scott CA, Feaster DJ, Gooden L, Matheson T, Haynes LF, Paltiel AD, Walensky RP.

Drug Alcohol Depend. 2013 Feb 1;128(1-2):90-7. doi: 10.1016/j.drugalcdep.2012.08.009.

6.

Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial.

Sanders GD, Anaya HD, Asch S, Hoang T, Golden JF, Bayoumi AM, Owens DK.

J Gen Intern Med. 2010 Jun;25(6):556-63. doi: 10.1007/s11606-010-1265-5.

7.

The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.

Hyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J, Losina E, Bassett IV, Pei PP, Paltiel AD, Resch S, Freedberg KA, Peter T, Walensky RP.

PLoS Med. 2014 Sep 16;11(9):e1001725. doi: 10.1371/journal.pmed.1001725.

8.

Programmatic cost evaluation of nontargeted opt-out rapid HIV screening in the emergency department.

Haukoos JS, Campbell JD, Conroy AA, Hopkins E, Bucossi MM, Sasson C, Al-Tayyib AA, Thrun MW; Denver ED HIV Opt-Out Study Group..

PLoS One. 2013 Dec 31;8(12):e81565. doi: 10.1371/journal.pone.0081565.

9.

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, Freedberg KA.

Ann Intern Med. 2006 Dec 5;145(11):797-806.

PMID:
17146064
10.

Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs.

Schackman BR, Leff JA, Barter DM, DiLorenzo MA, Feaster DJ, Metsch LR, Freedberg KA, Linas BP.

Addiction. 2015 Jan;110(1):129-43. doi: 10.1111/add.12754.

11.

Cost-effectiveness of HIV screening in patients older than 55 years of age.

Sanders GD, Bayoumi AM, Holodniy M, Owens DK.

Ann Intern Med. 2008 Jun 17;148(12):889-903.

12.

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK.

N Engl J Med. 2005 Feb 10;352(6):570-85.

13.

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Freedberg KA, Walensky RP.

N Engl J Med. 2005 Feb 10;352(6):586-95.

14.

Budget impact analysis of HIV testing in the VA healthcare system.

Anaya HD, Chan K, Karmarkar U, Asch SM, Bidwell Goetz M.

Value Health. 2012 Dec;15(8):1022-8. doi: 10.1016/j.jval.2012.08.2205.

15.

Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA.

Mauskopf J, Brogan A, Martin S, Smets E.

Pharmacoeconomics. 2010;28 Suppl 1:83-105. doi: 10.2165/11587470-000000000-00000.

PMID:
21182346
16.

Comparing the costs of HIV screening strategies and technologies in health-care settings.

Farnham PG, Hutchinson AB, Sansom SL, Branson BM.

Public Health Rep. 2008 Nov-Dec;123 Suppl 3:51-62.

17.

Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.

Pinkerton SD, Holtgrave DR, Pinkerton HJ.

Arch Intern Med. 1997 Sep 22;157(17):1972-80.

PMID:
9308509
18.

Implementing routine HIV screening in an urban pediatric emergency department.

Hack CM, Scarfi CA, Sivitz AB, Rosen MD.

Pediatr Emerg Care. 2013 Mar;29(3):319-23. doi: 10.1097/PEC.0b013e3182850910.

PMID:
23426243
19.

The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United States.

Eggman AA, Feaster DJ, Leff JA, Golden MR, Castellon PC, Gooden L, Matheson T, Colfax GN, Metsch LR, Schackman BR.

Sex Transm Dis. 2014 Sep;41(9):545-50. doi: 10.1097/OLQ.0000000000000168.

20.

Cost-effectiveness analysis and HIV screening: the emergency medicine perspective.

Hsu H, Walensky RP.

Ann Emerg Med. 2011 Jul;58(1 Suppl 1):S145-50. doi: 10.1016/j.annemergmed.2011.03.039. Review.

Items per page

Supplemental Content

Support Center